AMAG Pharmaceuticals Inc:企業の戦略的SWOT分析

◆英語タイトル:AMAG Pharmaceuticals Inc - Strategic SWOT Analysis Review
◆商品コード:GDPH3552SA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AMAG Pharmaceuticals Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

AMAG Pharmaceuticals Inc (AMAG) is a pharmaceutical company focused on the development and commercialization of specialty pharmaceutical products in therapeutic areas like maternal, women’s health, anemia management and hematology. Its products portfolio include Makena an auto-injector device, Feraheme for intravenous, Intrarosa for vaginal inserts and Vylees an auto-injector device. The company is developing two product pipelines; Ciraparantag is in Phase 2b trial of healthy volunteers and AMAG-423 is in phase 2b/3a trial. The company offers its products through a direct sales force and a network of distributors. AMAG is headquartered in Waltham, Massachusetts, the US.

AMAG Pharmaceuticals Inc Key Recent Developments

Oct 02,2020: Covis Group to acquire AMAG Pharmaceuticals for $647m
Aug 06,2020: AMAG Pharmaceuticals announces second quarter 2020 financial results and provides corporate update
Jun 12,2020: AMAG Pharmaceuticals to lay off 35 workers at Waltham, Massachusetts site
Jun 11,2020: AMAG Pharmaceuticals announces leadership changes
May 12,2020: AMAG Pharmaceuticals to lay off 32 workers at Waltham, Massachusetts site

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
AMAG Pharmaceuticals Inc – Key Facts
AMAG Pharmaceuticals Inc – Key Employees
AMAG Pharmaceuticals Inc – Key Employee Biographies
AMAG Pharmaceuticals Inc – Major Products and Services
AMAG Pharmaceuticals Inc – History
AMAG Pharmaceuticals Inc – Company Statement
AMAG Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AMAG Pharmaceuticals Inc – Business Description
Product Category: Feraheme
Performance
Product Category: Intrarosa
Performance
Product Category: Makena
Performance
Product Category: Other
Performance
R&D Overview
AMAG Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
AMAG Pharmaceuticals Inc – Strengths
AMAG Pharmaceuticals Inc – Weaknesses
AMAG Pharmaceuticals Inc – Opportunities
AMAG Pharmaceuticals Inc – Threats
AMAG Pharmaceuticals Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Aug 06, 2020: AMAG Pharmaceuticals announces second quarter 2020 financial results and provides corporate update
Jun 12, 2020: AMAG Pharmaceuticals to lay off 35 workers at Waltham, Massachusetts site
Jun 11, 2020: AMAG Pharmaceuticals announces leadership changes
May 12, 2020: AMAG Pharmaceuticals to lay off 32 workers at Waltham, Massachusetts site
May 11, 2020: AMAG Pharmaceuticals announces first quarter 2020 financial results and provides corporate update
Apr 28, 2020: AMAG Pharmaceuticals appoints Scott Myers as president and chief executive officer
Apr 16, 2020: AMAG Pharmaceuticals provides COVID-19 company update
Mar 04, 2020: AMAG Pharmaceuticals announces changes to medical development organization
Mar 04, 2020: AMAG Pharmaceuticals reports fourth quarter and full year 2019 financial results and provides corporate update
Jan 09, 2020: AMAG Pharmaceuticals announces leadership transition, results of strategic review to unlock shareholder value and financial update
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
AMAG Pharmaceuticals Inc, Key Facts
AMAG Pharmaceuticals Inc, Key Employees
AMAG Pharmaceuticals Inc, Key Employee Biographies
AMAG Pharmaceuticals Inc, Major Products and Services
AMAG Pharmaceuticals Inc, History
AMAG Pharmaceuticals Inc, Other Locations
AMAG Pharmaceuticals Inc, Subsidiaries
AMAG Pharmaceuticals Inc, Key Competitors
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Recent Deals Summary

★海外企業調査レポート[AMAG Pharmaceuticals Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Energizer Holdings, Inc.:企業の戦略・SWOT・財務情報
    Energizer Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Energizer Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Enable Midstream Partners LP (ENBL):企業の財務・戦略的SWOT分析
    Enable Midstream Partners LP (ENBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Viamet Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Viamet Pharmaceuticals Inc (Viamet), a subsidiary of Viamet Pharmaceuticals Holdings LLC is a provider of metalloenzyme inhibitors and antifungal agents. The company offers novel agents to treat both chronic and life threatening fungal infections. Its product pipeline includes clinical-stage …
  • Deoleo, S.A.:企業の戦略・SWOT・財務情報
    Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report Summary Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析
    Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • SANUWAVE Health Inc (SNWV):企業の製品パイプライン分析2018
    Summary Sanuwave Health Inc (Sanuwave), formerly Rub Music Enterprises Inc, is a medical device company that develops and commercializes noninvasive biological response activating devices. The company offers products such as dermapace, which is used in the treatment of chronic and acute conditions o …
  • RigNet Inc (RNET):石油・ガス:M&Aディール及び事業提携情報
    Summary RigNet Inc (RigNet) is a technology company that provides applications, customized communication services and cyber security solutions. Its managed services include remote communications and technology services for onshore and offshore drilling rigs, support vessels, production facilities, a …
  • Eby-Brown Company LLC:企業の戦略・SWOT・財務情報
    Eby-Brown Company LLC - Strategy, SWOT and Corporate Finance Report Summary Eby-Brown Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Daimler AG:企業のM&A・事業提携・投資動向
    Daimler AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Daimler AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Integer Holdings Corp (ITGR):医療機器:M&Aディール及び事業提携情報
    Summary Integer Holdings Corp (Integrated Holdings), formerly Greatbatch Inc is a medical device outsource manufacturer that designs and develops medical devices and power solutions for the medical and non-medical markets. The company offers products such as arthroscopic devices and components, lapa …
  • CSA Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary CSA Medical Inc (CSA Medical) is a medical device company that offers cryotherapy devices. The company provides spray cryotherapy medical device solutions to simplify procedures, improve patient outcomes, and reduce the cost of healthcare. Its truFreeze system delivers cold liquid nitrogen s …
  • Sophia Genetics SA:医療機器:M&Aディール及び事業提携情報
    Summary Sophia Genetics SA (Sophia Genetics) is a health tech company that provides technological solutions such as SOPHiA Artificial Intelligence for clinical genomics and next generation sequencing (NGS) data analysis. The company also provides dry lab, bundle solution, and integrated diagnostic s …
  • The Finish Line Inc:企業の戦略・SWOT・財務分析
    The Finish Line Inc - Strategy, SWOT and Corporate Finance Report Summary The Finish Line Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • G&W Electric Company:企業の戦略的SWOT分析
    G&W Electric Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Brewers Fayre:企業の戦略・SWOT・財務分析
    Brewers Fayre - Strategy, SWOT and Corporate Finance Report Summary Brewers Fayre - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sartorius AG (SRT):医療機器:M&Aディール及び事業提携情報
    Summary Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for …
  • Chemring Ordnance, Inc.:企業の戦略・SWOT・財務情報
    Chemring Ordnance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Chemring Ordnance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Emerald Resources NL (EMR):石油・ガス:M&Aディール及び事業提携情報
    Summary Emerald Resources NL (Emerald) is an oil and gas company that carries out mineral exploration and development. The company carries out acquisition, exploration, development and produces oil and natural gas, and gold deposits. Its projects include Okavu Gold project, and Magoffin County proje …
  • Foraco International SA (FAR):企業の財務・戦略的SWOT分析
    Summary Foraco International SA (Foraco) is a provider of drilling solutions for mining, energy, water and infrastructure projects. The company's drilling solutions include hydrogeological drilling, deep directional drilling, metallurgical sampling and large diameter drilling. It provides geological …
  • amcure GmbH-製薬・医療分野:企業M&A・提携分析
    Summary amcure GmbH (Amcure) is biopharmaceutical company which discovers and develops therapeutics for the treatment of cancer. It develops peptide-based compounds for the treatment of metastatic forms of cancer. The company’s lead candidate AMC303, is in Phase I clinical trial and used for the tre …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆